This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Lone Simonsen: Innovator in Vaccine Development
Introduction
Lone Simonsen is a notable inventor based in Chevy Chase, MD (US). He has made significant contributions to the field of vaccine development, particularly focusing on solutions for developing countries. His work aims to address critical health challenges faced by populations at risk of rotaviral diseases.
Latest Patents
Lone Simonsen holds a patent for a hexavalent bovine rotavirus reassortant composition designed for use in developing countries. This innovative vaccine composition provides protection against human rotaviral disease, specifically tailored for regions where such diseases are prevalent. The invention combines human-bovine reassortant rotavirus strains, incorporating the four most clinically significant VP7 serotypes of human rotavirus along with other local VP7 serotypes. This multivalent formulation ensures a high degree of infectivity and immunogenicity. Additionally, the patent outlines methods and administration protocols that facilitate an immunogenic response while minimizing the risk of intussusception.
Career Highlights
Lone Simonsen has dedicated his career to advancing public health through innovative vaccine research. His work has been instrumental in developing effective vaccine strategies that cater to the needs of vulnerable populations. He is affiliated with the United States of America, as represented by the Secretary, Department of Health and Human Services.
Collaborations
Throughout his career, Lone Simonsen has collaborated with esteemed colleagues, including Albert Z Kapikian and Timo Vesikari. These partnerships have further enriched his research and contributed to the advancement of vaccine development.
Conclusion
Lone Simonsen's contributions to vaccine innovation highlight his commitment to improving global health outcomes. His work in developing a hexavalent bovine rotavirus vaccine exemplifies the importance of targeted solutions for pressing health issues.